Lepu Biopharma Co., Ltd.

Lepu Biopharma Co., Ltd.verified

2157.HK

Price:

$5.88

Market Cap:

$9.64B

Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China. The company develops oncology drug candidates, including antibody-drug conjugates (ADC), oncolytic virus drugs, and immunotherapies. It develops immuno-oncology products, such as HX008 Anti-PD-1 mAb and LP002 Anti-PD-L1 mAb; ADC products, including MRG003 EGFR-targeted ADC, MRG002 HER2-targeted ADC, MRG001 CD20-targeted ADC, MRG004A TF-targeted ADC, and CMG901 CLDNI8.2-targeted ADC; CG0070 oncolytic virus; and other drug candidates, such as HX008+OH2, LP002+OH2, and HX008+LP002. The company was incorporated in 2018 and is head...[Read more]

Industry

Biotechnology

IPO Date

2022-02-23

Stock Exchange

HKSE

Ticker

2157.HK

The ROE as of December 2025 (TTM) for Lepu Biopharma Co., Ltd. (2157.HK) is -24.47%

According to Lepu Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -24.47%. This represents a change of 194.10% compared to the average of -8.32% of the last 4 quarters.

Lepu Biopharma Co., Ltd. (2157.HK) Historical ROE (quarterly & annually)

How has 2157.HK ROE performed in the past?

The mean historical ROE of Lepu Biopharma Co., Ltd. over the last ten years is -28.50%. The current -24.47% ROE has changed -14.12% with respect to the historical average. Over the past ten years (40 quarters), 2157.HK's ROE was at its highest in in the December 2023 quarter at 13.32%. The ROE was at its lowest in in the December 2021 quarter at -59.74%.

Quarterly (TTM)
Annual

Average

-28.50%

Median

-49.01%

Minimum

-120.83%

Maximum

126.82%

Lepu Biopharma Co., Ltd. (2157.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Lepu Biopharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.28%

Maximum Annual ROE = 126.82%

Minimum Annual Increase = -131.14%

Minimum Annual ROE = -120.83%

Quarterly (TTM)
Annual
YearROEChange
2024-58.53%2.28%
2023-2.46%-96.78%
2022-76.50%-36.69%
2021-120.83%206.00%
2020-39.49%-131.14%

Lepu Biopharma Co., Ltd. (2157.HK) Average ROE

How has 2157.HK ROE performed in the past?

The current ROE of Lepu Biopharma Co., Ltd. (2157.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-45.83%

5-year avg

-59.56%

10-year avg

-28.50%

Lepu Biopharma Co., Ltd. (2157.HK) ROE vs. Peers

How is 2157.HK’s ROE compared to its peers?

Lepu Biopharma Co., Ltd.’s ROE is less than Nanjing Leads Biolabs Co Ltd (0%), less than Alphamab Oncology (12.63%), less than Shanghai Haohai Biological Technology Co., Ltd. (6.84%), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (15.32%), less than HBM Holdings Limited (18.28%), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (-23.27%), greater than Ascletis Pharma Inc. (-13.49%), greater than CARsgen Therapeutics Holdings Limited (-39.53%), less than Abbisko Cayman Limited (7.17%), greater than China Traditional Chinese Medicine Holdings Co. Limited (-1.26%),

Build a custom stock screener for Lepu Biopharma Co., Ltd. (2157.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lepu Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lepu Biopharma Co., Ltd. (2157.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lepu Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Lepu Biopharma Co., Ltd.'s ROE?

How is the ROE calculated for Lepu Biopharma Co., Ltd. (2157.HK)?

What is the highest ROE for Lepu Biopharma Co., Ltd. (2157.HK)?

What is the 3-year average ROE for Lepu Biopharma Co., Ltd. (2157.HK)?

What is the 5-year average ROE for Lepu Biopharma Co., Ltd. (2157.HK)?

How does the current ROE for Lepu Biopharma Co., Ltd. (2157.HK) compare to its historical average?